GlassScriptPhysician profile
Trisha Gomez
NPI 1780170506
$18,769.89
in general payments reported to CMS, 2019-2025
26 companies · $8,384 in 2025
The $8,384 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,133 · 2023: $1,406 · 2024: $7,848 · 2025: $8,384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,269 · Food and Beverage: $6,796 · Grant: $3,000 · Education: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,269.20 |
| Food and Beverage | $6,795.63 |
| Grant | $3,000.00 |
| Education | $572.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,879.52 | 2022-2025 | Optis, Prostar, Perclose Proglide |
| Medtronic, INC. | $3,678.45 | 2022-2025 | Onyx Frontier, Corevalve Evolut R, Spiderfx |
| Abiomed | $1,364.64 | 2022-2025 | Impella |
| Boston Scientific Corporation | $1,297.79 | 2024-2025 | General - Therapies, Watchman Flx, Avvigo Guidance System |
| Shockwave Medical, INC | $570.95 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $391.74 | 2022-2025 | Camzyos, Eliquis |
| Heartflow, INC. | $289.28 | 2023 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $252.18 | 2022-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $173.02 | 2024 | Assure Wcd |
| Penumbra, INC. | $167.05 | 2024 | Indigo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.72 | 2025 | Jardiance |
| Bard Peripheral Vascular, INC. | $114.45 | 2024 | Rotarexs 6 F X 135 Cm |
| Philips North America LLC | $88.80 | 2023 | |
| Baxter Healthcare | $55.79 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Atricure, INC. | $49.76 | 2023-2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $42.81 | 2025 | Attruby |
| Irhythm Technologies, INC. | $39.54 | 2024 | Zio Monitor, Zio Xt Patch |
| Chiesi USA, INC. | $32.43 | 2025 | Cleviprex, Kengreal |
| Alnylam Pharmaceuticals INC. | $31.69 | 2025 | Onpattro |
| Amgen INC. | $30.25 | 2024 | Repatha |
| Scpharmaceuticals INC. | $21.44 | 2025 | |
| Novo Nordisk INC | $18.74 | 2025 | |
| Teleflex LLC | $17.71 | 2024 | Manta |
| Cardiva Medical, INC. | $17.67 | 2022 | |
| Terumo Medical Corporation | $14.63 | 2023 | Angio-Seal |
| Novartis Pharmaceuticals Corporation | $13.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trisha Gomez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.